p-STAT3 in luminal breast cancer: Integrated RNA-protein pooled analysis and results from the BIG 2-98 phase III trial
Amir Sonnenblick(Tel Aviv University), Christos Sotiriou(Université Libre de Bruxelles)
Cited by 21
Related Papers
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
|Annals of Oncology|2014|1.3k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k